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Abstract
Background—Among patients with documented stable coronary artery disease (CAD) and in 
whom no revascularization was performed, we compared the respective values of angiographic 
diameter stenosis (DS) and of fractional flow reserve (FFR) in predicting natural history.  
Methods—The present analysis included the 607 patients from the Fractional flow reserve versus 
angiography in multivessel evaluation 2 (FAME 2) trial in whom no revascularization was 
performed. FFR varied from 0.20 to 1.00 (average 0.74 ± 0.16) and DS (by QCA) varied from 
8% to 98% (average 53 ± 15). The primary end point, defined as VOCE (Vessel oriented clinical 
endpoint) at 2 years, was a composite of prospectively adjudicated cardiac death, vessel-related 
myocardial infarction, vessel-related urgent and not urgent revascularization. The stenoses were 
divided into 4 groups according to FFR and %DS values: 3RVLWLYH&RQFRUGDQFH3&))5
DS50%); Negative Concordance (NC: FFR>0.80; DS<50%); Positive Mismatch (PM: 
))5'61HJDWLYH0LVPDWFK10))5!'650%).  
Results—The rate of VOCE was highest in the PC group (Log Rank: X2=80.96; p=0.001), and 
lowest in the NC group. The rate of VOCE was higher in the PM group than in the NM group 
(H.R. 0.38, 95% C.I. 0.21 – 0.67; p=0.001). There was no significant difference in VOCE 
between the PC and the P0ERWKJURXSVZLWK))5 H.R. 0.77, 95% C.I. 0.57  – 1.09; 
p=0.149) and no significant difference in rate of VOCE between the NM and NC (both groups 
with FFR>0.80, H.R. 1.89, 95% C.I. 0.96  – 3.74; p=0.067).  
Conclusions—In patients with stable coronary disease, physiology (FFR) is a more important 
determinant of the natural history of coronary stenoses than anatomy (DS).  
Clinical Trial Registration—URL: https://clinicaltrials.gov Unique Identifier: NCT01132495.  
Key Words: fractional flow reserve; coronary angiography; coronary artery disease; coronary 
atherosclerosis; fractional flow reserve, stable coronary artery disease, Coronary physiology, 
Diameter stenosis, percutaneous coronary intervention
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Clinical Perspective
What is new?   
x The data were obtained in a unique population of patients in whom no mechanical 
revascularization was initially proposed whatever the severity of the stenoses.  
x The results indicate, for the first time, that the spontaneous clinical evolution (“natural 
history”) of coronary stenoses is better predicted by physiologic information than by 
angiography.  
What are the clinical implications?   
x Measurements of FFR should no longer be limited to angiographically intermediate 
stenosis, but should be contemplated in stenoses that are mild or severe by visual 
evaluation.  
x Since clinical outcome is the ultimate validation test for any new diagnostic metrics or 
new treatment strategy the present findings suggest that FFR should replace – or be used 
in conjunction with - the 50% DS criteria for the definition of obstructive CAD.    
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Fractional flow reserve FFR 1-5 has become the standard of reference for the invasive evaluation 
of coronary stenosis.1-4, 6 Patients with an FFR value >0.80 do not benefit from mechanical 
revascularization, while patients with an FFR GRbenefit from revascularization.7-9 FFR 
has now a class IA recommendation in the latest European Guidelines to guide myocardial 
revascularization in the absence of conclusive non-invasive diagnostic work-up.10  
Nevertheless, interventional cardiologists still prefer angiography for guiding decision 
making about revascularization, even in the absence of any budget and logistic constraints.11 The 
angiographic thresholds of 50% or 70% diameter stenosis (DS) are still used to define 
“obstructive” coronary artery disease to risk stratify patients,12 to justify revascularization, to 
serve as endpoint in studies on revascularization strategies,13, 14 and to validate other 
approaches15, 16.  
 Accordingly, we investigated the spontaneous, vessel oriented clinical outcome of 
patients from the FAME 2 trial in whom no revascularization was performed but in whom both 
the angiographic (DS) and functional (FFR) severity was known.8 The aim of the study was to 
compare the accuracy of both approaches in predicting the ‘natural history’ of coronary artery 
disease. 
Methods
Anonymized patient level data will be made available by the corresponding author for reasonable 
requests. Consent was not obtained for data sharing but the presented data are anonymized and 
risk of identification is minimal. 
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Patients  
The details of the FAME 2 trial have been previously reported.8 In short, the FAME 2 trial 
randomized consecutive patients with stable angina and in whom 1, 2 or 3 vessel percutaneous 
revascularization was based on the visual estimate of the angiogram. FFR was measured in all
stenoses that were considered potential targets for revascularization. Only if at least one lesion 
had an FFRWKHSDWLHQWZDVUDQGRPL]HGWRpercutaneous coronary intervention (PCI) with 
second generation drug eluting stent (DES) or medical therapy. When no stenosis had an 
))5SDWLHQWVZHUHHQUROOHGLQDUHJLVWU\DQGreceived the best medical therapy. A random 
sample of 50% of the registry patients underwent the same follow-up as the patients in the 
randomized trial. In the present analysis, we focused on patients who were treated only with best 
available MT alone and who had 2 years of clinical follow-up, namely patients randomized to 
best available MT (n=441) plus patients enrolled in the registry who underwent clinical follow-
up (n=166). All patients provided written informed consent. The trial was approved by the 
institutional review board at the 23 participating center in Europe and North America.  
Fractional flow reserve was measured in all the stenoses with the use of a pressure monitoring 
guide wire (PressureWire Certus or PressureWire Aeris, St. Jude Medical). Hyperemia was 
obtained with adenosine IV or IC according to the operator’s preference. 
Quantitative coronary angiography was performed in all stenosis by QCA was performed using 
the Medis software (the Netherlands). The operator was blinded to the FFR values and to 
patient’s clinical outcome. Angiographic DS, minimal lumen diameter (MLD, mm), lesion 
length (LL, mm), and the reference lumen diameter (RLD, mm) of the proximal and distal 
reference segments were measured. A cut-off value of 50% was used for DS and of 1.4 for MLD. 
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Syntax Score17 was calculated in all patients by 4 different investigators blinded to each other, 
unaware of the segment in which the FFR was measured. The mean values of the global 
SYNTAX score were taken for analysis.   
Study endpoints
The primary endpoint of the present analysis trial was the rate of major adverse cardiovascular 
event (MACE) at 2 years, defined as the composite of cardiovascular (CV) death, target vessel–
related myocardial infarction (MI), and ischemia driven target vessel revascularization (TVR) 
(both urgent and non-urgent). All outcomes were adjudicated by an independent clinical events 
committee whose members were unaware of the treatment assignments and of the FFR and 
angiographic details of the lesions. The present study specifically investigates the relationship 
between vessel-related events defined as “vessel oriented clinical endpoint” (VOCE) and lesion 
hemodynamics (FFR) or angiographic parameters (diameter stenosis and minimal luminal 
diameter). All the events at follow-up were blindly reviewed and were unequivocally assigned to 
the culprit vessel in case of MI and ischemia-driven TVR. When the identification of the culprit 
vessel was not possible/feasible (i.e., in case of CV death, no coronary angiography performed, 
or non–ST-segment elevation MI in patients with multivessel disease), the endpoint was assigned 
to all the stenotic vessels of those patients. According to their respective FFR and %DS values 
the lesions were divided in 4 groups, as follows3RVLWLYH&RQFRUGDQFH3&))5
DS50%); Negative Concordance (NC: FFR >0.80; DS <50%); Positive Mismatch (PM: FFR 
DS <50%); Negative Mismatch (NM: FFR >0.80; DS 50%) (Figure 1).
Statistical Analysis
All analyses were done on lesion level, using robust standard errors that accounted for the 
correlation of lesions within patients. Discrete variables are summarized as frequencies and 
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percentages. Continuous variables are presented as mean ± standard deviation (SD). Chi-square 
test was used for categorical variables. Time to event occurrence of clinical endpoints was 
analyzed by Kaplan Meier analysis with differences in survival curves assessed by log-rank test.
Hazard ratios and 95% confidence intervals [CI] were analyzed using Cox regression analysis
with robust standard errors as in a marginal model to account for clustering. Hazard ratios of 
continuous variables are expressed per one SD change. Multivariable adjustment was performed 
after forward selection of clinical and angiographic baseline characteristics associated with 
VOCE, with significance for addition to the model set at S Variables considered for 
forward selection were age, male gender, body mass index, smoker, hypertension, 
hypercholesterolemia, diabetes overall, insulin dependent diabetes, renal insufficiency, previous 
PCI, previous MI, silent ischemia, multivessel disease, ejection fraction, Canadian class score for 
angina, left circumflex / right coronary versus left anterior descending artery (LAD), '6
FFR  and SYNTAX score (in tertiles).  As the proportional hazard assumption was not 
satisfied for the multivariable model, we included an interaction term EHWZHHQ))5
YHUVXV!DQGWLPH90 days versus >90 days). In a sensitivity analysis, we forced the 
SYNTAX score as ordered tertiles into the multivariable model. Finally, we determined the 
SURJQRVWLFSHUIRUPDQFHRI'6DQG))5XVLQJ+DUUHOO¶VFDQGHVWLPDWHGWKHLQWHJUDWHG
discrimination improvement 18 RIDGGLQJ))5WR'6LQWKHPRGHOStatistical analyses 
were performed using IBM SPSS 20.0 statistical package (IBM Inc., New York, USA), 
GraphPad 5.0 (GraphPad Software Inc., CA, USA) and Stata 14.2 (StataCorp, College Station, 
Texas, USA). 
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Results
Patients and Vessels
Out of the 607 patients, both FFR and angiographic assessment of DS by QCA was obtained in 
567 (93%) patients (799 stenoses).  
Forty patients were excluded due to lack of angiographies or to impossibility to calculate the DS
related to one or more of the following factors:  inadequate filling of the vessel by contrast 
medium, overlap of side branches, guiding catheter not well visible, foreshortening of the 
stenotic segment, and chronic total occlusion. 
FFR values ranged from 0.20 to 1.00 (0.74 ± 0.16), and of DS from 8% to 98% (53 ± 
15%). There was a modest correlation between FFR and %DS (-0.55, 95% CI -0.61 to -0.49, 
p<0.001, Figure 1) and between FFR and MLD (0.38, 95% CI 0.10 to 0.66, p=0.009, Figure 2). 
FFR and %DS values were concordant (both positive or both negative) in 533 stenoses (66.7%)
and were discordant in (one criteria positive, the other negative) in 266 lesions (33.3%). A
SRVLWLYHFRQFRUGDQFH3&))5'650%) was present in 317 lesions (39.8%), a negative 
concordance (NC: FFR>0.80; DS<50%) was present in 216 lesions (27%), a positive mismatch 
30))5DS<50%) was present in 153 lesions (19.1%), and a negative mismatch (NM: 
FFR>0.80; DS50%) was present in 113 lesions (14.1%). 
Patients and lesions characteristics
Table 1 shows the baseline clinical characteristics, the angiographic and hemodynamic details of 
the whole population and of the four subgroups populations. Overall, the four groups were 
comparable except for peripheral vascular disease (highest rate in NM group vs lowest rate in PC 
group), the history of a previous PCI (highest rate in NM group vs lowest rate in PC group), the 
inter-tertile repartition of the Syntax Score, the diameter stenosis percentage (highest value in PC 
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group vs lowest value NC group), the minimal lumen diameter (highest value in NC group vs 
lowest value in PC group), the lesion length (highest value in PC group vs lowest value in NC 
group), the stenosis localizations, and the FFR distribution as well. A pairwise testing among the 
groups for the characteristics that had significant overall p-values is available in the 
supplemental data (Table S1).
Clinical correlates
Clinical 2-year follow-up was available in all patients. The total number of VOCE and their 
individual components are shown in Figure 3. Overall, VOCE’s occurred in 26% of cases. The 
rate of VOCE was highest in the group of stenoses with positive concordance (3&))5
DS50%; 125/317 lesions [39.4%]) and lowest in stenoses with a negative concordance (NC: 
FFR>0.80; DS<50%; 17/216 lesions [7.9%]). The rate of VOCE’s was similar in stenoses with a 
positive mismatch 30))5'6and with a positive concordance (50/153 lesions 
[32.7%] vs 125/317 lesions [39.4%], respectively, p =0.139. In contrast, the rate of VOCE’s of 
stenoses with negative mismatch 10))5!'6was lower as compared with 
stenoses with a positive mismatch (16/113 lesions [14.2%] 50/153 lesions [32.7%], respectively, 
p=0.001) but was not significantly different as compared with stenoses with a negative 
concordance (17/216 [7.9%], p =0.099).  
Figure 4 shows the time to event curves for VOCE and for their respective components 
in the 4 groups of patients. The color code is the same than in Figure 1. There was no significant 
difference in term of lesion related outcome between the negative mismatch (NM: FFR>0.80; 
'6DQGWKHQHJDWLYHFRQFRUGDQFH1&))5!'6HYHQWKRXJKWKHUHZDVD
trend (p=0.099). When the angiographic cut-off was set at 70% DS, the outcome results did not 
change (Figure S1A and S1B). Figure 5, S2, S3, S4 and S5 show the time to event curves for 
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the individual components of VOCE and illustrate that the differences in VOCE is driven by the 
rate of revascularizations. 
Figure 6 shows that the rate of VOCE over time is significantly larger when lesions have 
a DS  50% or when lesions have an FFR0.80, but the difference between the event curves is 
markedly larger for FFR than for DS.  
Table 2 shows the univariable analysis of predictors of VOCE. The global SYNTAX 
score was not found a significant predictor for vessel related outcome (Table 2).  
Table 3 shows the multivariable analysis of predictors of VOCE after forward selection 
of predictors. Only FFR, DS and silent ischemia were selected for the model. On average, 
))5 was associated with 4.16-fold increase in the hazard of VOCE DQG'6ZLWKD
1.36-IROGLQFUHDVH$IWHULQWURGXFWLRQRIDQLQWHUDFWLRQWHUP))5ZDVDVVRFLDWHGZLWKD
7.28-fold increase in the hazard of VOCE during the first 90 days, and with a 3.29-fold increase 
in the hazard of VOCE occurring later than 90 days. Table S2 presents results of multivariable 
analyses after tertiles of the SYNTAX score were forced into the model; results for FFR
DQG'6ZHUHVLPLODU Harrell’s c was 0.61 (95% CI 0.58 to 0.65) for the prognostic 
performance RI'6DQG0.65 (95% CI 0.63 to 0.68) IRUWKHSHUIRUPDQFHRI))57KH
LQWHJUDWHGGLVFULPLQDWLRQLPSURYHPHQWRIDGGLQJ))5WR'6LQWKHPRGHOZDV1.44
(95% CI 1.12 to 1.77, p<0.001). 
Discussion
Summary of Findings
The present analysis describes the 2-year outcome of a unique patient population, namely 
patients with angiographically and physiologically fully characterized coronary artery disease 
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and in whom no revascularization was proposed initially. Events were adjudicated by an 
independent clinical event committee, unaware of the angiogram and the FFR values. DS and 
FFR were compared side-by-side to clinical outcome data. The data indicate that the FFR value 
predicts the natural history significantly better than DS, suggesting that “physiology trumps 
anatomy”19. In addition, among the stenoses with mismatch between DS and FFR, more than 
half had a low FFR in the presence of an angiographically mild stenosis.   
Rate and reasons for ‘mismatch’  
In the present study, an approximately 33% rate of mismatch between DS and FFR was found. 
This is similar that what we found in previous work by Toth at al. 15 (36%) as well as by Park et 
al.20 in non-left main stenoses (39%) and in left main stenoses (40%). This relatively high rate of 
apparent discordance (‘mismatch’) between anatomy and physiology is actually not surprising as 
it relates to many different factors. First there are a number of specific reasons like inaccuracy of 
border detection, foreshortening of the stenotic segment, superimposition of side branches, 
asymmetry of the stenotic segment, as well as inaccuracies of the pressure measurements. 
Second, like every metrics in medicine, cut-off values of both DS and FFR are surrounded by a 
grey zone. However, the most important reason for the disconnect between anatomy and 
physiology relates to the myocardial mass that depends on the stenosis and to the vasodilatory 
capacity of the vascular bed. The reference diameter partially accounts for the myocardial mass. 
This is the reason why the optimal cut-off value for DS decreases when the diameter of the 
vessel increases, typically in LM and proximal LAD.15, 20 Also in the present data, LAD stenoses 
are under-represented in the group of ‘negative mismatch’ and over-represented in the group 
with a ‘positive mismatch’. Stated another way, any stenosis in the LAD is more likely to be 
hemodynamically significant than in other arteries, even when its angiographic appearance is 
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only mild. In contrast, the angiogram does not provide any clue about the vasodilatory 
capabilities of the microvasculature in the downstream territory. This is illustrated by the finding 
that for a similar degree of angiographic severity, FFR is higher in older patients and in diabetic 
patients.20-22 Moreover, FFR takes into account the entire epicardial resistance between the 
guiding and the pressure sensor while DS provides more focal information. Finally, it is likely 
that discrete morphologic lesion characteristics not captured by the angiogram like lesion 
eccentricity, surface roughness and the presence of plaque rupture influence lesion 
hemodynamics.20  
Outcome according to physiology versus anatomy  
There is a general believe that stenosis severity on angiography is related to worse outcome. 
Many previous studies reported only a very elusive link between angiographic severity of the 
lesions and patients outcome.23, 24 The present data indicate that, indeed, lesion-related outcome 
is better when DS is low (Figure 6). In contrast, very robust data support a strong negative 
relationship between outcome and non-invasive signs of reversible myocardial ischemia.25 A
meta-analysis by Johnson and al26 indicates that the higher the FFR the better the outcome. Yet, 
in many of these patients revascularization was performed based on the FFR values, which 
inevitably influences the relationship between the index value of FFR and the natural history of 
the patients. Recent data by Barbato et al27 confirmed this ‘dose-response’ relationship between 
the actual value of FFR and clinical outcome. There are, however, very little data comparing 
side-by-side the prognostic value of anatomic and functional data in the same patients.28 In 
addition, in none of these studies the patients had been followed during a long period of time 
without mechanical intervention, and the events adjudicated by an independent event committee. 
The present study is unique by the fact that, regardless of the severity of the stenoses, the patients 
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were not treated by revascularization, so that the outcome data of the present study can be 
regarded as the ‘natural history’ of the stenoses in stable patients, without interference of PCI or 
CABG on the fate of these lesions. 
 In the present study, FFR predicted outcome markedly better than DS. In addition, the 
present data show that when a lesion is angiographically mild but hemodynamically significant, 
the event rate is as high than when both angiography and hemodynamics indicate a significant
lesion. Conversely, in case of angiographically significant stenoses but hemodynamic non-
significant stenosis the clinical outcome is as favorable than when both angiography and 
hemodynamics indicate a non-significant stenoses. In other words, what determines lesions-
related outcome is less its angiographic appearance than its hemodynamic significance. 
The SYNTAX SCORE was developed in angiographic 3-vessel disease patients to characterize 
the complexity of the stenoses and the extent of the atherosclerotic burden 17. The SYNTAX 
score has proven very useful in clinical decision-making between CABG and PCI in these 3-
vessel disease patient mainly because CABG is largely ‘immune’ to the anatomic complexity of 
the disease while the technical aspects of the PCI procedures are heavily influenced by these 
anatomic characteristics 29. It might sound intuitively logical to find some relationship between 
the SYNTAX score and the ‘natural history’ of the stenosis. This was not found in the present 
dataset. Yet, one have to realize that the SYNTAX score have been developed for 3 vessel 
disease patients while in the FAME 2 the majority of patients had 1 or 2-vessel disease. 
Accordingly, the global SYNTAX score was markedly lower in FAME 2 than in most studies 
focusing on 3 vessel-disease patients. In addition the present analysis focused on the lesion level 
outcome while the SYNTAX score is a global estimates of atherosclerotic burden and 
complexity. Data derived from coronary CT angiography very convincingly indicate that a high 
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atherosclerotic burden is an independent predictor of ‘hard’ events even in patients with 
angiographically non-obstructive coronary artery disease 30. Therefore, the absence of 
relationship found between the SYNTAX score and the rate of VOCE seen in the present study 
should be interpreted with prudence. This total atherosclerotic burden is reflected by a lower 
FFR and is probably one of the mechanistic links to explain why FFR predicts events better that 
angiographic diameter stenosis.
Limitations
A number of limitations should be taken into account. First, like in the original FAME 2 trial, 
neither the patients nor the physicians were blinded to the FFR values.31 Second, this analysis 
was not pre-specified in the initial protocol. Therefore, reliable QCA analysis was not possible 
for technical reasons in a sizable proportion of stenoses (23%). It cannot be excluded that this 
has contributed to an enrichment of the trial population in mild to moderate stenoses. For the 
same reasons, the numbers in each subgroup of patients are relatively small. Even with these 
relatively small subgroups one can distinguish statistical trends toward differences in the rate of 
VOCE between the groups with a negative concordance (FFR >0.8, DS<50%) and the group 
with a negative mismatch (FFR >0.80, DS>50%). It can therefore not be excluded that with 
larger numbers the difference in outcome between the PM and PC groups as well as between the 
NM and NC groups would have become significant. However, this would not have changed the 
main conclusion of the study.  Third, left main stenoses were not included in FAME 2. Therefore 
the conclusions of the present analysis should be restricted to non-LM stenoses. Yet, Park et al20
showed that LM stenoses - more than non-LM stenosis - have a high proportion of positive 
mismatch, precisely these lesions that are underestimated by angiography and in which FFR is 
important because revascularization of these lesions have important prognostic implications. 
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Fourth, the angiograms were not performed with the intention to perform QCA nor to calculate 
the SYNTAX score. This might have contributed to a lower accuracy of these angiographic 
approaches.  
Conclusion
From this side-by-side comparison of DS and FFR to lesion-related outcome, it appears that the
main determinant of the ‘natural history’ of a lesion is its hemodynamic significance rather than 
its angiographic appearance. Nowadays, DS is the cornerstone of the definition of CAD.32 Since 
clinical outcome is the ultimate validation test for any new treatment or metrics the present 
findings suggest that FFR should replace the 50% DS criteria for the definition of obstructive 
CAD.   
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Table 1. Baseline Clinical, Angiographic, and Fractional Flow Reserve (FFR) Characteristics  
PC 
(n=317)
NC 
(n=216)
PM 
(n=153)
NM 
(n=113) p
Patients characteristics
Age 64.0±10.1 63.8±10.0 64.7±9.9 64.9±10.0 0.70
Male (%) 250 (79) 250 (116) 250 (163) 250 (221) 0.076
Body Mass Index 28.8±4.4 27.9±4.2 28.2±5.0 28.1±4.5 0.16
Smoker (%) 70 (22) 70 (32) 70 (46) 70 (62) 0.78
Hypertension (%) 247 (78) 247 (114) 247 (161) 247 (219) 0.072
Dyslipidemia (%) 249 (79) 249 (115) 249 (163) 249 (220) 0.80
Diabetes Overall (%) 83 (26) 83 (38) 83 (54) 83 (73) 0.36
Diabetes ID (%) 32 (10) 32 (15) 32 (21) 32 (28) 0.20
Renal Failure (%) 8 (3) 8 (4) 8 (5) 8 (7) 0.40
Peripheral Vascular Disease (%) 31 (10) 31 (14) 31 (20) 31 (27) 0.003
Cerebro-Vascular Accident (%) 11 (3) 11 (5) 11 (7) 11 (10) 0.094
Previous Myocardial Infarction (%) 114 (36) 114 (53) 114 (75) 114 (101) 0.70
Previous PCI (%) 39 (12) 39 (18) 39 (25) 39 (35) 0.010
Silent Ischemia (%) 53 (17) 53 (25) 53 (35) 53 (47) 0.91
Left Ventricular Ejection Fraction <50% (%) 40 (13) 40 (19) 40 (26) 40 (35) 0.78
Multi Vessel Disease (%) 221 (70) 221 (102) 221 (144) 221 (196) 0.24
Syntax <0.001
Tertile 1 136 (45) 91 (46) 50 (35) 57 (53)
Tertile 2 83 (27) 55 (28) 45 (31) 23 (21)
Tertile 3 85 (28) 52 (26) 48 (34) 28 (26)
Angina 0.96
   Asymptomatic 31 (10) 17 (8) 18 (12) 12 (11)
CCS class 1 67 (21) 49 (23) 35 (23) 32 (28)
CCS class 2 145 (46) 107 (50) 68 (44) 50 (44)
CCS class 3 48 (15) 24 (11) 23 (15) 13 (12)
CCS class 4 26 (8) 19 (9) 9 (6) 6 (5)
Angiographic characteristics 
Diameter Stenosis Percentage 66.2±10.7 39.9±7.7 40.4±7.1 58.2±6.9 <0.001
8-49 (%) - 216 (100) 153 (100) - -
50-69 (%) 203 (64) - - 104 (92) -
70-98 (%) 114 (36) - - 7 (8) -
Minimal Lumen Diameter 0.9±0.8 1.6±0.3 1.5±0.4 1.2±0.4 <0.001
Reference Lumen Diameter 3.2±9.6 2.8±0.6  2.6±0.5 2.8±0.8 0.71
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Lesion Length 16.7±37.8 10.6±6.8 11.9±8.1 15.1±9.4 <0.001
Left Anterior Descending Artery (%) 142 (45) 99 (46) 98 (64) 43 (38) <0.001
Left Circumflex Artery (%) 71 (22) 64 (30) 27 (18) 27 (24) 0.001
Right Coronary Artery (%) 104 (33) 53 (25) 28 (18) 43 (38) <0.001
Fractional Flow Reserve 0.62±0.13 0.87±0.05 0.71±0.09 0.87±0.05 <0.001
 317 (100) - 153 (100) - -
>0.8 (%) - 216 (100) - 113 (100) -
BMI, Body mass index; Diabetes ID, insulin dependent; PCI, percutaneous coronary intervention; MI, 
Myocardial Infarction; MVD, Multivessel disease; EF, Ejection fraction; CCS, Canadian class score; 
LCx/RCA, Left circumflex artery/ right coronary artery; FFR, Fractional flow reserve. All P-values 
account for the correlation of lesions within patients. Note that p-values are global p-values for equality 
across all 4 groups. A pairwise testing among the groups for the characteristics that had significant overall 
p-values is available in the supplemental data (Table S1).
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Table 2. Univariable predictors of vessel oriented clinical endpoint (VOCE)
VOCE
yes (n=208) no (n=591) HR p
Patients characteristics
Age 64.4 (SD 10.9) 64.1 (SD 9.7) 1.01 (0.85 to 1.21) 0.88
Male 158 (76) 440 (74) 1.04 (0.72 to 1.50) 0.85
BMI 28.4 (SD 4.2) 28.3 (SD 4.6) 1.02 (0.88 to 1.18) 0.78
Risk factors
Smoker 42 (20) 123 (21) 0.95 (0.66 to 1.38) 0.81
Hypertension 163 (78) 452 (76) 1.07 (0.73 to 1.57) 0.72
Hypercholerolemia 161 (77) 471 (80) 0.90 (0.64 to 1.28) 0.57
Diabetes overall 58 (28) 146 (25) 1.11 (0.79 to 1.56) 0.54
Diabetes ID 25 (12) 45 (8) 1.47 (0.90 to 2.39) 0.12
Renal insufficiency 6 (3) 18 (3) 1.06 (0.37 to 3.00) 0.92
History 
Previous PCI 40 (19) 105 (18) 1.09 (0.72 to 1.64) 0.69
Previous MI 73 (35) 233 (39) 0.82 (0.59 to 1.13) 0.21
Silent Ischemia 25 (12) 103 (17) 0.69 (0.42 to 1.14) 0.15
Presentation 
MVD 143 (69) 440 (74) 0.79 (0.58 to 1.08) 0.15
EF<50% 26 (13) 88 (15) 0.78 (0.50 to 1.22) 0.28
Syntax 0.15
Tertile 1 76 (37) 258 (44) Ref.
Tertile 2 60 (29) 146 (25) 1.74 (0.95 to 3.17)
Tertile 3 60 (29) 153 (26) 1.37 (0.73 to 2.57)
Angina
Asymptomatic 17 (8) 61 (10) Ref. 0.28
CCS class 1 44 (21) 139 (24) 1.09 (0.58 to 2.06)
CCS class 2 98 (47) 272 (46) 1.26 (0.70 to 2.26)
CCS class 3 37 (18) 71 (12) 1.80 (0.93 to 3.48)
CCS class 4 12 (6) 48 (8) 0.93 (0.40 to 2.17)
Angiographic characteristics 
LCx/RCA 108 (52) 274 (46) 1.23 (0.94 to 1.61) 0.13
'6 141 (68) 289 (49) 2.01 (1.50 to 2.70) 0.00
))5 175 (84) 294 (50) 4.55 (3.06 to 6.77) 0.00
Numbers of events id followed by percentage in brackets. VOCE, Vessel oriented clinical endpoint; C.I.,
Confidence interval; BMI, Body mass index; Diabetes ID, insulin dependent; PCI, percutaneous coronary 
intervention; MI, Myocardial Infarction; MVD, multivessel diseas); EF, Ejection fraction; CCS, Canadian 
class score; LCx/RCA, Left circumflex artery/ right coronary artery; DS, Diameter stenosis; FFR,
Fractional flow reserve.  
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Table 3. Multivariable predictors of vessel oriented clinical endpoint (VOCE)
HR (95% CI) p
Model 1: Average estimates
))5 4.16 (2.74 to 6.31) <0.001
'6 1.36 (1.00 to 1.85) 0.050
Silent Ischemia 0.65 (0.40 to 1.07) 0.092
Model 2: Accounting for interaction of FFR with time
))5
up to 90 days 7.28 (2.92 to 18.2) <0.001
above 90 days 3.29 (1.79 to 4.78) <0.001
'6 1.36 (1.00 to 1.85) 0.049
Silent Ischemia 0.65 (0.40 to 1.07) 0.092
Multivariable model after forward selection of clinical and angiographic baseline characteristics 
associated with VOCE reported in Table 2, with significance IRUDGGLWLRQWRWKHPRGHOVHWDWS
Proportional hazards test based on Schoenfeld residuals positive for Model 1 (p=0.013), negative for 
Model 2 (p=0.32) DIWHULQWURGXFWLRQRIDQLQWHUDFWLRQWHUPEHWZHHQ))5YV!DQGWLPH
days vs >90 days). CI, confidence interval; VOCE, Vessel oriented clinical endpoint; DS, diameter 
stenosis; FFR, fractional flow reserve.
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Figure Legends 
Figure 1. Scatter plot of the angiographic diameter stenosis (DS) versus the fractional flow 
reserve values (FFR). Color code: Red dots: Positive Concordance 3&))5'650%);
Blue dots: Negative Concordance (NC: FFR>0.80; DS<50%); Orange dots: Positive Mismatch
30))5'6; Green dots: Negative Mismatch 10))5!'6
Figure 2. Scatter plot of the minimal lumen diameter (MLD) versus the fractional flow reserve 
values (FFR).
Figure 3. Rate (%) of Vessel Oriented Clinical Endpoint (VOCE) and their individual 
components according to the 4 different subgroups according to the values of Fractional Flow 
Reserve (FFR) and Percent Diameter Stenosis (DS). The color code is the same as in Figure 1. N. 
events: Number of events; HR:Hazard ratio; 95% CI: 95% Confidence Interval. 
Figure 4. Kaplan Meier survival curve of 4 Groups according to the values of Fractional Flow 
Reserve (FFR) and Percent Diameter Stenosis (DS). The color code is the same as in Figure 1. 
Figure 5.  Kaplan Meier survival curve of 4 Groups according to the values of Fractional Flow 
Reserve (FFR) and Percent Diameter Stenosis (DS) for the cumulative incidence of vessel 
related urgent and not urgent revascularization (A) and for the cumulative incidence of vessel 
related myocardial infarction and cardiovascular death (B). The color code is the same as in 
Figure 1.
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Figure 6. Kaplan Meier survival according to the values of Percent Diameter Stenosis (DS) and 
Fractional Flow Reserve (FFR).  
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 Figure legends 
 
Figure S1A :  Rate (%) of Vessel Oriented Clinical Endpoint (VOCE) and their individual 
components according to the 4 different subgroups according to the values 
of Fractional Flow Reserve (FFR) and Percent Diameter Stenosis (DS). 
Color code: Red dots: Positive Concordance (PC: FFR≤0.80; DS≥70%); 
Blue dots: Negative Concordance (NC: FFR>0.80; DS<70%); Orange dots: 
Positive Mismatch (PM: FFR≤0.80; DS<70%); Green dots: Negative 
Mismatch (NM: FFR>0.80; DS≥70%). 
 
Figure S1B :  Scatter plot of the angiographic diameter stenosis (DS) versus the fractional 
flow reserve values (FFR). Color code: Red dots: Positive Concordance 
(PC: FFR≤0.80; DS≥70%); Blue dots: Negative Concordance (NC: 
FFR>0.80; DS<70%); Orange dots: Positive Mismatch (PM: FFR≤0.80; 
DS<70%); Green dots: Negative Mismatch (NM: FFR>0.80; DS≥70%). 
 
Figure S2 : Rate (%) of Urgent Revascularizations  (UR) according to the 4 different 
subgroups according to the values of Fractional Flow Reserve (FFR) and 
Percent Diameter Stenosis (DS). Color code: Red dots: Positive 
Concordance (PC: FFR≤0.80; DS≥50%); Blue dots: Negative Concordance 
(NC: FFR>0.80; DS<50%); Orange dots: Positive Mismatch (PM: 
FFR≤0.80; DS<50%); Green dots: Negative Mismatch (NM: FFR>0.80; 
DS≥50%). 
 
Figure S3 : Rate (%) of Non Urgent Revascularizations  (NUR) according to the 4 
different subgroups according to the values of Fractional Flow Reserve 
(FFR) and Percent Diameter Stenosis (DS). Color code: Same as Figure 
S2. 
 
Figure S4 : Rate (%) of Myocardial Infarction  (MI) according to the 4 different 
subgroups according to the values of Fractional Flow Reserve (FFR) and 
Percent Diameter Stenosis (DS). Color code: Same as Figure S2. 
 
Figure S5 : Rate (%) of CV Death according to the 4 different subgroups according to 
the values of Fractional Flow Reserve (FFR) and Percent Diameter 
Stenosis (DS). Color code: Same as Figure S2. 
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Figure S1A :  Rate (%) of Vessel Oriented Clinical Endpoint (VOCE) and their individual 
components according to the 4 different subgroups according to the values 
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Figure S1B :  Scatter plot of the angiographic diameter stenosis (DS) versus the fractional 
flow reserve values (FFR). Color code: Red dots: Positive Concordance 
(PC: FFR≤0.80; DS≥70%); Blue dots: Negative Concordance (NC: 
FFR>0.80; DS<70%); Orange dots: Positive Mismatch (PM: FFR≤0.80; 
DS<70%); Green dots: Negative Mismatch (NM: FFR>0.80; DS≥70%). 
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Figure S2 : Rate (%) of Urgent Revascularizations  (UR) according to the 4 different 
subgroups according to the values of Fractional Flow Reserve (FFR) and 
Percent Diameter Stenosis (DS). Color code: Red dots: Positive 
Concordance (PC: FFR≤0.80; DS≥50%); Blue dots: Negative Concordance 
(NC: FFR>0.80; DS<50%); Orange dots: Positive Mismatch (PM: 
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Figure S3 : Rate (%) of Non Urgent Revascularizations  (NUR) according to the 4 
different subgroups according to the values of Fractional Flow Reserve 
(FFR) and Percent Diameter Stenosis (DS). Color code: Same as Figure 
S2. 
 
 
 
 
 
 
 
 
 
Figure S4 
 
 	
Figure S4 : Rate (%) of Myocardial Infarction  (MI) according to the 4 different 
subgroups according to the values of Fractional Flow Reserve (FFR) and 
Percent Diameter Stenosis (DS). Color code: Same as Figure S2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5 
 	
Figure S5 : Rate (%) of CV Death according to the 4 different subgroups according to 
the values of Fractional Flow Reserve (FFR) and Percent Diameter 
Stenosis (DS). Color code: Same as Figure S2. 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S1 : P-values for pairwise analyses of the variables from table 1 with p<0.05. 
 PC NC PM NM 
Male Ref. 0.035 0.55 0.039 
 - Ref. 0.21 0.75 
 - - Ref. 0.19 
Peripheral Vascular Disease Ref. 0.37 0.042 0.14 
 - Ref. 0.005 0.37 
 - - Ref. 0.010 
Previous PCI Ref. 0.011 0.003 0.020 
 - Ref. 0.80 0.92 
 - - Ref. 0.75 
Diameter Stenosis Ref. <0.001 <0.001 <0.001 
 - Ref. 0.54 <0.001 
 - - Ref. <0.001 
Minimal Lumen Diameter Ref. <0.001 <0.001 <0.001 
 - Ref. 0.001 <0.001 
 - - Ref. <0.001 
Lesion Lenght Ref. 0.005 0.030 0.48 
 - Ref. 0.14 <0.001 
 - - Ref. 0.003 
Left Anterior Descending Ref. 0.100 <0.001 0.001 
 - Ref. <0.001 0.039 
 - - Ref. <0.001 
Left Circumflex Artery Ref. 0.062 0.12 0.009 
 - Ref. 0.003 0.31 
 - - Ref. <0.001 
Right Coronary Artery Ref. 0.98 <0.001 0.22 
 - Ref. <0.001 0.26 
 - - Ref. <0.001 
Fractional Flow Reserve Ref. <0.001 <0.001 <0.001 
 - Ref. <0.001 0.22 
 - - Ref. <0.001 
 
Legend: P-values for pairwise analyses of the variables from table 1 with p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2: Multivariable predictors of vessel oriented clinical endpoint (VOCE) 
including SYNTAX 
 
 HR (95% CI) p 
Model 1: Average estimates   
 FFR<0.8  4.01 (2.60 to 6.20) <0.001 
 DS ≥50%  1.34 (0.97 to 1.84) 0.074 
  SYNTAX   1.12 (0.93 to 1.36) 0.240 
Model 2: Accounting for interaction of FFR with time  
 FFR<0.80    
  up to 90 days 6.65 (2.65 to 16.7) <0.001 
  above 90 days 3.22 (1.69 to 4.76) <0.001 
 DS ≥50%  1.34 (0.97 to 1.84) 0.073 
  SYNTAX   1.12 (0.93 to 1.36) 0.241  
HR, Hazard ratio; CI, confidence interval; VOCE, Vessel oriented clinical endpoint; DS, diameter stenosis; 
FFR, fractional flow reserve.  
 
